The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly

References

• Kahn SR, Lim W, Dunn AS. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(suppl2):e195S–e226S. doi:10.1378/chest.11-2296
   PubMedGoogle Scholar
• Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med. 1991;151:933–938. doi:10.1001/archinte.1991.00400050081016
   PubMed Web of Science ®Google Scholar
• Stein PD, Hull RD, Kayali F, Ghali WA, Alshab AK, Olson RE. Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med. 2004;164:2260–2265.
   PubMed Web of Science ®Google Scholar
• Engbers MJ, Hylckama AV, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010;8:2105–2112. doi:10.1111/j.1538-7836.2010.03986.x
   PubMed Web of Science ®Google Scholar
• Bauersachs RM. Use of anticoagulants in elderly patients. Thromb Res. 2012;129:107–115. doi:10.1016/j.thromres.2011.09.013
   PubMed Web of Science ®Google Scholar
• Johnson SA, G P E, Rondina MT. Pathogenesis, diagnosis, and treatment of venous thromboembolism in older adults. J Am Geriatr Soc. 2016;64:1869–1878. doi:10.1111/jgs.14279
   PubMed Web of Science ®Google Scholar
• Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000;160:769–774. doi:10.1001/archinte.160.6.769
   PubMed Web of Science ®Google Scholar
• Schulman S, Lindmarker P, Holmstrom M, et al. Postthrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006;4:734–742.
   PubMed Web of Science ®Google Scholar
• Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362:523–526. doi:10.1016/S0140-6736(03)14111-6
   PubMed Web of Science ®Google Scholar
• Eichinger S, Heinze G, Jandeck LM, et al. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation. 2010;121:1630–1636. doi:10.1161/CIRCULATIONAHA.109.925214
   PubMed Web of Science ®Google Scholar
• Kyrle PA, Minar E, Bialonczyk C, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350:2558–2563. doi:10.1056/NEJMoa032959
   PubMed Web of Science ®Google Scholar
• Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost. 2012;10:1019–1025.
   PubMed Web of Science ®Google Scholar
• Schulman S, Kearon C. Subcommittee on control of anticoagulation of the scientific and standardization committee of the international society on thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694.
   PubMed Web of Science ®Google Scholar
• Spencer FA, Emery C, Lessard D, et al. The Worcester venous thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006;21(7):722–727. doi:10.1111/j.1525-1497.2006.00458.x
   PubMed Web of Science ®Google Scholar
• Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86(1):452–463. doi:10.1055/s-0037-1616243
   PubMed Web of Science ®Google Scholar
• Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160(6):761–768. doi:10.1001/archinte.160.6.761
   PubMed Web of Science ®Google Scholar
• White RH, Zhou H, Romano PS. Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Intern Med. 1998;158(9):1005–1010. doi:10.1001/archinte.158.9.1005
   PubMedGoogle Scholar
• Spencer FA, Gurwitz JH, Schulman S, et al. Venous thromboembolism in older adults: a community-based study. Am J Med. 2014;127(e533):530–537. doi:10.1016/j.amjmed.2014.02.011
   PubMedGoogle Scholar
• Spencer FA, Gore JM, Lessard D, et al. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost. 2008;100:780–788. doi:10.1160/TH08-04-0255
   PubMed Web of Science ®Google Scholar
• Lauber S, Limacher A, Tritschler T, et al. Predictors and outcomes of recurrent venous thromboembolism in elderly patients. Am J Med. 2018;131(6):703.e7–703.e16. doi:10.1016/j.amjmed.2017.12.015
   PubMed Web of Science ®Google Scholar
• Piran S, Schulman S. Management of recurrent venous thromboembolism in patients with cancer: a review. Thromb Res. 2018;164(Suppl 1):S172–S177. doi:10.1016/j.thromres.2017.12.019
   PubMedGoogle Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352. doi:10.1016/j.chest.2015.11.026
   PubMed Web of Science ®Google Scholar
• Jara-Palomares L, Solier-Lopez A, Elias-Hernandez T, et al. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis. Br J Cancer. 2018;119(8):915–921. doi:10.1038/s41416-018-0269-5
   PubMed Web of Science ®Google Scholar
• Nemeth B, Lijfering WM, Nelissen RGHH, et al. Risk and risk factors associated with recurrent venous thromboembolism following surgery in patients with history of venous thromboembolism. JAMA Netw Open. 2019;2(5):e193690. doi:10.1001/jamanetworkopen.2019.3690
   PubMed Web of Science ®Google Scholar
• Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809–815. doi:10.1001/archinte.160.6.809
   PubMed Web of Science ®Google Scholar
• Lu DY, Huang CC, Huang PH, et al. Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study. BMC Cardiovasc Disord. 2014;14:187. doi:10.1186/1471-2261-14-187
   PubMed Web of Science ®Google Scholar
• Xin G, Wei Z, Ji C, et al. Metformin uniquely prevents thrombosis by inhibiting platelet activation and mtDNA release. Sci Rep. 2016;6:36222.
   PubMed Web of Science ®Google Scholar
• de Jager J, Kooy A, Schalkwijk C, et al. Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. J Intern Med. 2014;275:59–70. doi:10.1111/joim.12128
   PubMed Web of Science ®Google Scholar
• Charles MA, Morange P, Eschwege E, Andre P, Vague P, Juhan-Vague I. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 study. Biguanides and the prevention of the risk of obesity. Diabetes Care. 1998;21:1967–1972. doi:10.2337/diacare.21.11.1967
   PubMed Web of Science ®Google Scholar
• Derosa G, Gaddi AV, Piccinni MN. Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. Pharmacotherapy. 2005;25(5):637–645. doi:10.1592/phco.25.5.637.63587
   PubMed Web of Science ®Google Scholar
• Sobel BE, Hardison RM, Genuth S. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the bypass angioplasty revascularization investigation – diabetes (BARI 2D) trial. Circulation. 2011;124:695–703. doi:10.1161/CIRCULATIONAHA.110.014860
   PubMed Web of Science ®Google Scholar
• Faller N, Limacher A, Méan M, et al. Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism: a prospective cohort study. Am J Med. 2017;130(2):198–206. doi:10.1016/j.amjmed.2016.09.008
   PubMed Web of Science ®Google Scholar